R. Krebs

1.3k total citations
57 papers, 1.0k citations indexed

About

R. Krebs is a scholar working on Surgery, Molecular Biology and Transplantation. According to data from OpenAlex, R. Krebs has authored 57 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Surgery, 17 papers in Molecular Biology and 15 papers in Transplantation. Recurrent topics in R. Krebs's work include Transplantation: Methods and Outcomes (39 papers), Angiogenesis and VEGF in Cancer (11 papers) and Renal Transplantation Outcomes and Treatments (10 papers). R. Krebs is often cited by papers focused on Transplantation: Methods and Outcomes (39 papers), Angiogenesis and VEGF in Cancer (11 papers) and Renal Transplantation Outcomes and Treatments (10 papers). R. Krebs collaborates with scholars based in Finland, Germany and United States. R. Krebs's co-authors include Karl Lemström, Antti I. Nykänen, Petri Koskinen, Kari Alitalo, Raimo Tuuminen, Mikko Keränen, Jussi Tikkanen, Seppo Ylä‐Herttuala, S. Syrjälä and Roope Sihvola and has published in prestigious journals such as Circulation, Circulation Research and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

R. Krebs

52 papers receiving 1.0k citations

Peers

R. Krebs
R. Krebs
Citations per year, relative to R. Krebs R. Krebs (= 1×) peers Raimo Tuuminen

Countries citing papers authored by R. Krebs

Since Specialization
Citations

This map shows the geographic impact of R. Krebs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Krebs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Krebs more than expected).

Fields of papers citing papers by R. Krebs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Krebs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Krebs. The network helps show where R. Krebs may publish in the future.

Co-authorship network of co-authors of R. Krebs

This figure shows the co-authorship network connecting the top 25 collaborators of R. Krebs. A scholar is included among the top collaborators of R. Krebs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Krebs. R. Krebs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dhaygude, Kishor, R. Krebs, Maija Puhka, et al.. (2025). Extracellular vesicles in lung donor plasma: Potential indicators of donor organ quality. Journal of Thoracic and Cardiovascular Surgery. 170(3). 902–913.
2.
Syrjälä, S., Kishor Dhaygude, Raimo Tuuminen, et al.. (2024). Donor plasma VEGF-A as a biomarker for myocardial injury and primary graft dysfunction after heart transplantation. The Journal of Heart and Lung Transplantation. 43(10). 1677–1690. 1 indexed citations
3.
Dhaygude, Kishor, R. Krebs, Maija Puhka, et al.. (2023). Transcriptomic Landscape of Circulating Extracellular Vesicles in Heart Transplant Ischemia–Reperfusion. Genes. 14(11). 2101–2101. 2 indexed citations
4.
Syrjälä, S., Kishor Dhaygude, Raimo Tuuminen, et al.. (2023). Severe primary graft dysfunction of the heart transplant is associated with increased plasma and intragraft proinflammatory cytokine expression. The Journal of Heart and Lung Transplantation. 42(6). 807–818. 8 indexed citations
5.
Dhaygude, Kishor, Mayank Saraswat, Sakari Joenväärä, et al.. (2021). Plasma proteome of brain-dead organ donors predicts heart transplant outcome. The Journal of Heart and Lung Transplantation. 41(3). 311–324. 7 indexed citations
6.
Keränen, Mikko, Alireza Raissadati, Antti I. Nykänen, et al.. (2016). Increased myeloid cell hypoxia-inducible factor-1 delays obliterative airway disease in the mouse. The Journal of Heart and Lung Transplantation. 35(5). 671–678. 2 indexed citations
7.
Tuuminen, Raimo, et al.. (2016). Simvastatin pretreatment reduces caspase-9 and RIPK1 protein activity in rat cardiac allograft ischemia-reperfusion. Transplant Immunology. 37. 40–45. 13 indexed citations
8.
Raissadati, Alireza, S. Syrjälä, Georgia Zarkada, et al.. (2015). Ischemia–Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts. American Journal of Transplantation. 16(4). 1160–1172. 37 indexed citations
9.
Syrjälä, S., Antti I. Nykänen, Raimo Tuuminen, et al.. (2015). Donor Heart Treatment With COMP-Ang1 Limits Ischemia-Reperfusion Injury and Rejection of Cardiac Allografts. American Journal of Transplantation. 15(8). 2075–2084. 17 indexed citations
10.
Tuuminen, Raimo, Alexey Dashkevich, Mikko Keränen, et al.. (2015). Platelet-derived Growth Factor-B Protects Rat Cardiac Allografts From Ischemia-reperfusion Injury. Transplantation. 100(2). 303–313. 13 indexed citations
11.
Syrjälä, S., Raimo Tuuminen, Antti I. Nykänen, et al.. (2014). Angiopoietin-2 Inhibition Prevents Transplant Ischemia-Reperfusion Injury and Chronic Rejection in Rat Cardiac Allografts. American Journal of Transplantation. 14(5). 1096–1108. 31 indexed citations
12.
Tuuminen, Raimo, Antti I. Nykänen, Pipsa Saharinen, et al.. (2013). Donor Simvastatin Treatment Prevents Ischemia-Reperfusion and Acute Kidney Injury by Preserving Microvascular Barrier Function. American Journal of Transplantation. 13(8). 2019–2034. 36 indexed citations
13.
Keränen, Mikko, Raimo Tuuminen, S. Syrjälä, et al.. (2013). Differential Effects of Pharmacological HIF Preconditioning of Donors Versus Recipients in Rat Cardiac Allografts. American Journal of Transplantation. 13(3). 600–610. 15 indexed citations
14.
Krebs, R., Jussi Tikkanen, Michael Jeltsch, et al.. (2012). Critical Role of VEGF-C/VEGFR-3 Signaling in Innate and Adaptive Immune Responses in Experimental Obliterative Bronchiolitis. American Journal Of Pathology. 181(5). 1607–1620. 39 indexed citations
15.
Syrjälä, S., Maria Hollmén, Raimo Tuuminen, et al.. (2012). Effect of simvastatin on development of obliterative airway disease: An experimental study. The Journal of Heart and Lung Transplantation. 31(2). 194–203. 7 indexed citations
16.
Keränen, Mikko, Antti I. Nykänen, R. Krebs, et al.. (2010). Cardiomyocyte-targeted HIF-1α gene therapy inhibits cardiomyocyte apoptosis and cardiac allograft vasculopathy in the rat. The Journal of Heart and Lung Transplantation. 29(9). 1058–1066. 13 indexed citations
17.
Syrjälä, S., Mikko Keränen, Raimo Tuuminen, et al.. (2010). Increased Th17 rather than Th1 alloimmune response is associated with cardiac allograft vasculopathy after hypothermic preservation in the rat. The Journal of Heart and Lung Transplantation. 29(9). 1047–1057. 29 indexed citations
18.
Krebs, R., Jussi Tikkanen, Antti I. Nykänen, et al.. (2005). Dual Role of Vascular Endothelial Growth Factor in Experimental Obliterative Bronchiolitis. American Journal of Respiratory and Critical Care Medicine. 171(12). 1421–1429. 37 indexed citations
20.
Koskinen, Petri, et al.. (1997). A Dose-Dependent Inhibitory Effect of Cyclosporine A on Obliterative Bronchiolitis of Rat Tracheal Allografts. American Journal of Respiratory and Critical Care Medicine. 155(1). 303–312. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026